Clinical Trials Directory

Trials / Recruiting

RecruitingNCT03142022

Sleep-disordered Breathing After Solid Organ Transplantation

Status
Recruiting
Phase
Study type
Observational
Enrollment
300 (estimated)
Sponsor
Universitaire Ziekenhuizen KU Leuven · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Sleep-disordered breathing (SDB) describes a group of disorders in which partial or complete cessation of breathing occurs many times throughout the night, resulting in daytime sleepiness or fatigue that interferes with a person's ability to function and reduces quality of life. Transplantation has become an important treatment modality for end-stage organ failure. Transplant recipients are now living longer and, hence, develop chronic adverse medical conditions. Furthermore, transplantation is associated with weight gain. Despite the high prevalence of poor sleep and cardiovascular conditions among transplant patients, SDB is not well studied in these patients.

Detailed description

The primary research objective is to evaluate the prevalence, incidence and type (central or obstructive) of SDB in patients after lung transplantation. Secondary research objectives are the evaluation of correlations between severity of SDB and clinical findings (weight, medical therapy, heart function, lung function, renal function, graft failure, …). Furthermore, the investigators will evaluate the relationship between SDB and cardiovascular morbidity.

Conditions

Interventions

TypeNameDescription
OTHERNo intervention - Diagnostic polysomnography at 1 year after lung transplantation

Timeline

Start date
2014-11-01
Primary completion
2025-12-01
Completion
2025-12-01
First posted
2017-05-05
Last updated
2024-07-03

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT03142022. Inclusion in this directory is not an endorsement.